CRBP
Corbus Pharmaceuticals Holdings, Inc.
Price Chart
No historical data available
Latest Quote
$10.91
-0.22 (-1.98%)
Current Price
| Previous Close | $11.13 |
| Open | $11.13 |
| Day High | $11.29 |
| Day Low | $10.74 |
| Volume | 583,248 |
Stock Information
| Shares Outstanding | 19.34M |
| Total Debt | $4.26M |
| Cash Equivalents | $117.94M |
| Net Income | $-101.90M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $211.01M |
| EPS (TTM) | $-5.98 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
đ° Latest News
No news articles available at the moment. Check back later for updates on CRBP.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $0 | $1,872,000 | $3,858,000 | - |
| Total Expenses | $85,310,000 | $48,721,000 | $45,078,000 | $34,835,445 |
| Other Income Expense | $1,243,000 | $4,073,000 | $2,696,000 | $-5,379,367 |
| Other Non Operating Income Expenses | $1,243,000 | $4,073,000 | $2,696,000 | $-48,773 |
| Net Non Operating Interest Income Expense | $5,530,000 | $4,439,000 | $-2,222,000 | $-2,132,091 |
| Interest Expense Non Operating | $0 | $1,872,000 | $3,858,000 | - |
| Operating Expense | $85,310,000 | $48,721,000 | $45,078,000 | $34,835,445 |
| General And Administrative Expense | $15,215,000 | $16,499,000 | $13,910,000 | $18,698,619 |
| Total Other Finance Cost | - | - | $2,923,974 | $2,132,091 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Net Interest Income | $5,530,000 | $4,439,000 | $-2,222,000 | $-2,132,091 |
| Interest Income | $5,530,000 | $6,311,000 | $1,636,000 | - |
| Normalized Income | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-37,016,309 |
| Net Income From Continuing And Discontinued Operation | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Total Operating Income As Reported | $-85,310,000 | $-48,721,000 | $-45,078,000 | $-39,835,445 |
| Net Income Common Stockholders | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Net Income | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Net Income Including Noncontrolling Interests | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Net Income Continuous Operations | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Pretax Income | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Interest Income Non Operating | $5,530,000 | $6,311,000 | $1,636,000 | - |
| Operating Income | $-85,310,000 | $-48,721,000 | $-45,078,000 | $-34,835,445 |
| Special Income Charges | - | - | $0 | $-5,000,000 |
| Per Share | ||||
| Diluted EPS | $-5.90 | $-3.68 | $-10.31 | $-10.15 |
| Basic EPS | $-5.90 | $-3.68 | $-10.31 | $-10.15 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-78,304,000 | $-37,749,000 | $-40,105,000 | $-28,741,856 |
| Reconciled Depreciation | $233,000 | $588,000 | $641,000 | $762,995 |
| EBITDA (Bullshit earnings) | $-78,304,000 | $-37,749,000 | $-40,105,000 | $-34,072,450 |
| EBIT | $-78,537,000 | $-38,337,000 | $-40,746,000 | $-34,835,445 |
| Diluted Average Shares | $13,317,116 | $10,915,413 | $4,327,568 | $4,170,674 |
| Basic Average Shares | $13,317,116 | $10,915,413 | $4,327,568 | $4,170,674 |
| Diluted NI Availto Com Stockholders | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Research And Development | $70,095,000 | $32,222,000 | $31,168,000 | $16,136,826 |
| Selling General And Administration | $15,215,000 | $16,499,000 | $13,910,000 | $18,698,619 |
| Other Gand A | $15,215,000 | $16,499,000 | $13,910,000 | $18,698,619 |
| Total Unusual Items | - | - | $8,519 | $-5,330,594 |
| Total Unusual Items Excluding Goodwill | - | - | $8,519 | $-5,330,594 |
| Gain On Sale Of Security | - | - | $8,519 | $-330,594 |
| Other Special Charges | - | - | - | $5,000,000 |
Fetched: 2026-08-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $147,503,000 | $142,428,000 | $-6,905,000 | $32,990,017 |
| Total Assets | $168,195,000 | $155,879,000 | $28,272,000 | $66,311,940 |
| Total Non Current Assets | $1,241,000 | $2,903,000 | $4,726,000 | $6,130,838 |
| Current Assets | $166,954,000 | $152,976,000 | $23,546,000 | $60,181,102 |
| Other Current Assets | $3,015,000 | $3,629,000 | $2,448,000 | $791,616 |
| Restricted Cash | $670,000 | $285,000 | $192,000 | $192,475 |
| Cash Cash Equivalents And Short Term Investments | $163,269,000 | $149,062,000 | $20,906,000 | $59,197,011 |
| Cash And Cash Equivalents | $28,492,000 | $17,198,000 | $13,724,000 | $17,002,715 |
| Cash Equivalents | $27,141,000 | $12,151,000 | $9,695,000 | $13,197,559 |
| Cash Financial | $1,351,000 | $5,047,000 | $4,029,000 | $3,805,156 |
| Other Non Current Assets | - | $385,000 | $690,000 | $632,771 |
| Prepaid Assets | - | - | - | - |
| Receivables | - | - | - | - |
| Debt | ||||
| Total Debt | $1,633,000 | $3,239,000 | $20,885,000 | $25,089,635 |
| Long Term Debt And Capital Lease Obligation | $0 | $1,633,000 | $3,239,000 | $20,659,780 |
| Current Debt And Capital Lease Obligation | $1,633,000 | $1,606,000 | $17,646,000 | $4,429,855 |
| Net Debt | - | - | $2,485,000 | $2,130,703 |
| Current Debt | - | - | $16,209,000 | $3,148,992 |
| Other Current Borrowings | - | - | $15,908,000 | $2,795,669 |
| Long Term Debt | - | - | - | $15,984,426 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $20,692,000 | $13,451,000 | $35,177,000 | $33,321,923 |
| Total Non Current Liabilities Net Minority Interest | $0 | $1,633,000 | $3,283,000 | $20,681,985 |
| Current Liabilities | $20,692,000 | $11,818,000 | $31,894,000 | $12,639,938 |
| Payables And Accrued Expenses | $16,200,000 | $7,936,000 | $14,209,000 | $5,948,264 |
| Payables | $2,215,000 | $4,786,000 | $3,179,000 | $2,173,963 |
| Accounts Payable | $2,215,000 | $4,786,000 | $3,179,000 | $2,173,963 |
| Current Notes Payable | - | $0 | $301,000 | $353,323 |
| Interest Payable | - | $0 | $1,342,098 | $916,108 |
| Other Non Current Liabilities | - | - | $44,000 | $22,205 |
| Other Current Liabilities | - | - | $39,000 | $36,868 |
| Equity | ||||
| Common Stock Equity | $147,503,000 | $142,428,000 | $-6,905,000 | $32,990,017 |
| Total Equity Gross Minority Interest | $147,503,000 | $142,428,000 | $-6,905,000 | $32,990,017 |
| Stockholders Equity | $147,503,000 | $142,428,000 | $-6,905,000 | $32,990,017 |
| Gains Losses Not Affecting Retained Earnings | $-53,000 | $35,000 | $-1,000 | $-126,092 |
| Other Equity Adjustments | $-53,000 | $35,000 | $-1,000 | $-126,092 |
| Retained Earnings | $-555,430,000 | $-476,893,000 | $-436,684,000 | $-392,080,667 |
| Other | ||||
| Ordinary Shares Number | $17,611,511 | $12,179,482 | $4,423,683 | $4,171,296 |
| Share Issued | $17,611,511 | $12,179,482 | $4,423,683 | $4,171,296 |
| Tangible Book Value | $147,503,000 | $142,428,000 | $-6,905,000 | $32,990,017 |
| Invested Capital | $147,503,000 | $142,428,000 | $9,304,000 | $52,123,435 |
| Working Capital | $146,262,000 | $141,158,000 | $-8,348,000 | $47,541,164 |
| Capital Lease Obligations | $1,633,000 | $3,239,000 | $4,676,000 | $5,956,217 |
| Total Capitalization | $147,503,000 | $142,428,000 | $-6,905,000 | $48,974,443 |
| Additional Paid In Capital | $702,984,000 | $619,285,000 | $429,780,000 | $425,196,359 |
| Capital Stock | $2,000 | $1,000 | $0 | $417 |
| Common Stock | $2,000 | $1,000 | $0 | $417 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $1,633,000 | $3,239,000 | $4,675,354 |
| Current Capital Lease Obligation | $1,633,000 | $1,606,000 | $1,437,000 | $1,280,863 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,859,000 | $2,276,000 | $2,325,488 | $2,224,951 |
| Current Accrued Expenses | $13,985,000 | $3,150,000 | $11,030,000 | $3,774,301 |
| Net PPE | $1,241,000 | $2,518,000 | $4,036,000 | $5,498,067 |
| Accumulated Depreciation | $-4,306,000 | $-4,073,000 | $-3,556,000 | $-3,093,223 |
| Gross PPE | $5,547,000 | $6,591,000 | $7,592,000 | $8,591,290 |
| Leases | $3,331,000 | $3,331,000 | $3,331,000 | $3,330,855 |
| Other Properties | $1,082,000 | $2,133,000 | $3,063,000 | $3,884,252 |
| Machinery Furniture Equipment | $1,134,000 | $1,127,000 | $1,198,000 | $1,376,183 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $134,777,000 | $131,864,000 | $7,182,000 | $42,194,296 |
Fetched: 2026-08-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-64,498,000 | $-41,794,000 | $-36,100,000 | $-37,557,884 |
| Operating Activities | ||||
| Operating Cash Flow | $-64,491,000 | $-41,794,000 | $-36,100,000 | $-37,544,435 |
| Cash Flow From Continuing Operating Activities | $-64,491,000 | $-41,794,000 | $-36,100,000 | $-37,544,435 |
| Operating Gains Losses | - | - | $-20,435 | $751,135 |
| Investing Activities | ||||
| Capital Expenditure | $-7,000 | - | - | $-13,449 |
| Investing Cash Flow | $-1,641,000 | $-121,310,000 | $35,642,000 | $30,074,133 |
| Cash Flow From Continuing Investing Activities | $-1,641,000 | $-121,310,000 | $35,642,000 | $30,074,133 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $77,426,000 | $182,058,000 | $53,000 | $0 |
| Financing Cash Flow | $77,426,000 | $166,578,000 | $-2,821,000 | $-533,615 |
| Cash Flow From Continuing Financing Activities | $77,426,000 | $166,578,000 | $-2,821,000 | $-533,615 |
| Net Common Stock Issuance | $77,426,000 | $182,058,000 | $53,000 | $0 |
| Common Stock Issuance | $77,426,000 | $182,058,000 | $53,000 | $0 |
| Net Other Financing Charges | - | - | $-190,902 | - |
| Other | ||||
| Repayment Of Debt | $0 | $-15,480,000 | $-3,247,000 | $-2,367,594 |
| Interest Paid Supplemental Data | $0 | $2,818,000 | $2,607,000 | $1,969,583 |
| End Cash Position | $29,162,000 | $17,868,000 | $14,394,000 | $17,672,615 |
| Beginning Cash Position | $17,868,000 | $14,394,000 | $17,673,000 | $25,676,532 |
| Changes In Cash | $11,294,000 | $3,474,000 | $-3,279,000 | $-8,003,917 |
| Net Issuance Payments Of Debt | $0 | $-15,480,000 | $-2,874,000 | $-533,615 |
| Net Long Term Debt Issuance | $0 | $-15,480,000 | $-2,874,000 | $-119,000 |
| Long Term Debt Payments | $0 | $-15,480,000 | $-3,247,000 | $-1,500,729 |
| Net Investment Purchase And Sale | $-1,634,000 | $-121,310,000 | $35,642,000 | $30,079,482 |
| Sale Of Investment | $161,457,000 | $59,494,000 | $69,527,000 | $116,421,376 |
| Purchase Of Investment | $-163,091,000 | $-180,804,000 | $-33,885,000 | $-86,341,894 |
| Net PPE Purchase And Sale | $-7,000 | $0 | $0 | $-5,349 |
| Purchase Of PPE | $-7,000 | $0 | $0 | $-13,449 |
| Change In Working Capital | $9,120,000 | $-5,576,000 | $4,094,000 | $-3,298,652 |
| Change In Other Current Liabilities | $-1,606,000 | $-1,481,000 | $-1,259,000 | $-1,136,948 |
| Change In Other Current Assets | $1,051,000 | $1,142,000 | $764,000 | $615,897 |
| Change In Payables And Accrued Expense | $9,041,000 | $-4,008,000 | $6,059,000 | $-4,350,995 |
| Change In Accrued Expense | $11,390,000 | $-5,611,000 | $5,031,000 | $-4,094,160 |
| Change In Payable | $-2,349,000 | $1,603,000 | $1,028,000 | $-256,835 |
| Change In Account Payable | $-2,349,000 | $1,603,000 | $1,028,000 | $-256,835 |
| Change In Prepaid Assets | $634,000 | $-1,229,000 | $-1,470,000 | $1,573,394 |
| Other Non Cash Items | $-229,000 | $585,000 | $805,000 | $742,478 |
| Stock Based Compensation | $6,288,000 | $6,145,000 | $3,470,000 | $5,719,637 |
| Amortization Of Securities | $-1,366,000 | $-3,327,000 | $-506,000 | $124,875 |
| Depreciation Amortization Depletion | $233,000 | $588,000 | $641,000 | $762,995 |
| Depreciation And Amortization | $233,000 | $588,000 | $641,000 | $762,995 |
| Depreciation | $233,000 | $588,000 | $641,000 | $1,487,853 |
| Net Income From Continuing Operations | $-78,537,000 | $-40,209,000 | $-44,604,000 | $-42,346,903 |
| Issuance Of Debt | - | $0 | $373,000 | $1,833,979 |
| Long Term Debt Issuance | - | $0 | $373,000 | $1,381,729 |
| Net Short Term Debt Issuance | - | - | $-52,660 | $-414,615 |
| Short Term Debt Payments | - | - | $-425,980 | $-866,865 |
| Short Term Debt Issuance | - | - | $373,320 | $452,250 |
| Sale Of PPE | - | - | $0 | $8,100 |
| Gain Loss On Investment Securities | - | - | $3,295 | $81,380 |
| Net Foreign Currency Exchange Gain Loss | - | - | $-23,730 | $648,520 |
| Gain Loss On Sale Of PPE | - | - | $0 | $21,235 |
| Change In Receivables | - | - | - | $0 |
| Asset Impairment Charge | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | - |
Fetched: 2026-08-21